Market Cap 15.93B
Revenue (ttm) 20.92B
Net Income (ttm) 582.08M
EPS (ttm) N/A
PE Ratio 15.32
Forward PE 12.22
Profit Margin 2.78%
Debt to Equity Ratio 0.44
Volume 302,300
Avg Vol 495,104
Day's Range N/A - N/A
Shares Out 586.83M
Stochastic %K 56%
Beta 0.87
Analysts Sell
Price Target $28.62

Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 49 6172 609 0
Address:
Else-Kröner-Strasse 1, Bad Homburg, Germany
SparkyReturns
SparkyReturns Jun. 24 at 3:33 PM
$TAK Something to look at. Small cap investing idea: ICU recently beat down from a capital raise a few days ago, which was just reported will make them Nasdaq compliant. Waiting on confirmation. ICU has a unique SCD device which treats Acute Kidney Infection and has also been approved for compassionate and emergency use for Sepsis. FDA loves it so much has granted multiple breakthrough device designations, and has even awarded grants. Also Dept of Defense money to study use in burn or trauma cases. The device can calm the cytokine storm which can happen in a variety of conditions from AKI to sepsis to heart attacks to burn cases, Covid, etc. TAM in the tens of Billions. Current market cap approx. 8M. Read that again. Let that sink in. Reversal incoming. Cheers! $SYK $DVA $FMS
0 · Reply
ZacksResearch
ZacksResearch Jun. 24 at 1:04 PM
$FMS unveils “FME Reignite” strategy — is this the game-changer for renal care? 🌟 🚀 Targeting €1.05B in sustainable cost savings by 2027 with FME25+ 🩺 Launching 5008X CAREsystem in the U.S., promising improved clinical outcomes 💶 €1B share buyback & 30-40% dividend payout to boost investor confidence Discover the full strategy breakdown here 👉 https://www.zacks.com/commentary/2543827/fms-stock-likely-to-gain-on-new-optimization-plan-fme-reignite?cid=sm-stocktwits-2-2543827-body&ADID=SYND_STOCKTWITS_TWEET_2_2543827_BODY
0 · Reply
ZacksResearch
ZacksResearch Jun. 24 at 11:46 AM
$FMS launching bold turnaround plan — is this the catalyst bulls needed? New “FME Reignite” initiative aims for €1B in cost savings, tech improvements, and juiced shareholder returns. Full breakdown here 👉 https://www.zacks.com/stock/news/2543827/fms-stock-likely-to-gain-on-new-optimization-plan-fme-reignite?cid=sm-stocktwits-2-2543827-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2543827_TEASER
0 · Reply
Estimize
Estimize Jun. 23 at 9:03 PM
Wall St is expecting 0.49 EPS for $FMS Q2 [Reporting 08/05 BMO] http://www.estimize.com/intro/fms?chart=historical&metric_name=eps&utm_cont
0 · Reply
IntensiveCareUnit
IntensiveCareUnit Jun. 23 at 6:26 PM
$ICU I just think we're sleeping on buyout instead of commercial ramp up if IA goes well in august. Fresenius $FMS and DaVita $DVA make so much money every quarter, why would they not want to control a product that directly impacts their main product of dialysis? Fresenius already knows about it, they manufacture the product. Why not bring it all in house? It'd be chump change for them.
1 · Reply
FractionalShareWhale
FractionalShareWhale Jun. 18 at 2:45 PM
$FMS 🔥🔥🔥
0 · Reply
LewisDaKat
LewisDaKat Jun. 18 at 12:55 AM
News Article Fresenius Medical Care Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Allocation Framework to further enhance Value Creation https://marketwirenews.com/news-releases/fresenius-medical-care-launches-its-strategy-fme-rei-5173163048165934.html $FMS
0 · Reply
wolverine
wolverine Jun. 17 at 9:11 AM
$CRMD $FMS capital markets day presentation: https://freseniusmedicalcare.com/content/dam/fresenius-medical-care/global/en/03_investors/pdf/events/cmd/2025/FME_CMD_2025_Main_Presentation.pdf
3 · Reply
GJ_Rockabilt
GJ_Rockabilt Jun. 11 at 2:25 PM
$FMS My son, in early twenties, needs a Kidney. He is "O Positive" Blood Type. Please, let me know if you are interested in donating one. Thanks.
0 · Reply
wolverine
wolverine Jun. 9 at 6:04 PM
$CRMD how do we think a $FMS & $CRMD initial order will be announced? Do they both announce? Does only Cormedix? Does $FMS announce at the capital markets day next Tuesday 6/17?
2 · Reply
Latest News on FMS
5 Stocks To Ride The German Market Rally

Jun 16, 2025, 3:06 PM EDT - 8 days ago

5 Stocks To Ride The German Market Rally

BNTX SAP


Fresenius Medical Care's stock falls on Fresenius' stake sale

Mar 4, 2025, 3:57 AM EST - 4 months ago

Fresenius Medical Care's stock falls on Fresenius' stake sale


Fresenius Medical Care: A 'Buy' Going Into 2025

Jan 31, 2025, 6:20 AM EST - 5 months ago

Fresenius Medical Care: A 'Buy' Going Into 2025


Fresenius Medical Care returns to Dax 40 Index

Dec 20, 2024, 11:23 AM EST - 6 months ago

Fresenius Medical Care returns to Dax 40 Index


Fresenius Medical Care: Let's Look At The Upside

Oct 4, 2024, 4:04 PM EDT - 9 months ago

Fresenius Medical Care: Let's Look At The Upside


Fresenius Medical Care AG (FMS) Q2 2024 Earnings Call Transcript

Jul 30, 2024, 12:39 PM EDT - 11 months ago

Fresenius Medical Care AG (FMS) Q2 2024 Earnings Call Transcript


US FTC probing DaVita, Fresenius Medical, Politico reports

Jul 13, 2024, 9:16 AM EDT - 1 year ago

US FTC probing DaVita, Fresenius Medical, Politico reports

DVA


Fresenius Medical Care: Significant Upside Remains

Jun 25, 2024, 6:15 AM EDT - 1 year ago

Fresenius Medical Care: Significant Upside Remains


SparkyReturns
SparkyReturns Jun. 24 at 3:33 PM
$TAK Something to look at. Small cap investing idea: ICU recently beat down from a capital raise a few days ago, which was just reported will make them Nasdaq compliant. Waiting on confirmation. ICU has a unique SCD device which treats Acute Kidney Infection and has also been approved for compassionate and emergency use for Sepsis. FDA loves it so much has granted multiple breakthrough device designations, and has even awarded grants. Also Dept of Defense money to study use in burn or trauma cases. The device can calm the cytokine storm which can happen in a variety of conditions from AKI to sepsis to heart attacks to burn cases, Covid, etc. TAM in the tens of Billions. Current market cap approx. 8M. Read that again. Let that sink in. Reversal incoming. Cheers! $SYK $DVA $FMS
0 · Reply
ZacksResearch
ZacksResearch Jun. 24 at 1:04 PM
$FMS unveils “FME Reignite” strategy — is this the game-changer for renal care? 🌟 🚀 Targeting €1.05B in sustainable cost savings by 2027 with FME25+ 🩺 Launching 5008X CAREsystem in the U.S., promising improved clinical outcomes 💶 €1B share buyback & 30-40% dividend payout to boost investor confidence Discover the full strategy breakdown here 👉 https://www.zacks.com/commentary/2543827/fms-stock-likely-to-gain-on-new-optimization-plan-fme-reignite?cid=sm-stocktwits-2-2543827-body&ADID=SYND_STOCKTWITS_TWEET_2_2543827_BODY
0 · Reply
ZacksResearch
ZacksResearch Jun. 24 at 11:46 AM
$FMS launching bold turnaround plan — is this the catalyst bulls needed? New “FME Reignite” initiative aims for €1B in cost savings, tech improvements, and juiced shareholder returns. Full breakdown here 👉 https://www.zacks.com/stock/news/2543827/fms-stock-likely-to-gain-on-new-optimization-plan-fme-reignite?cid=sm-stocktwits-2-2543827-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2543827_TEASER
0 · Reply
Estimize
Estimize Jun. 23 at 9:03 PM
Wall St is expecting 0.49 EPS for $FMS Q2 [Reporting 08/05 BMO] http://www.estimize.com/intro/fms?chart=historical&metric_name=eps&utm_cont
0 · Reply
IntensiveCareUnit
IntensiveCareUnit Jun. 23 at 6:26 PM
$ICU I just think we're sleeping on buyout instead of commercial ramp up if IA goes well in august. Fresenius $FMS and DaVita $DVA make so much money every quarter, why would they not want to control a product that directly impacts their main product of dialysis? Fresenius already knows about it, they manufacture the product. Why not bring it all in house? It'd be chump change for them.
1 · Reply
FractionalShareWhale
FractionalShareWhale Jun. 18 at 2:45 PM
$FMS 🔥🔥🔥
0 · Reply
LewisDaKat
LewisDaKat Jun. 18 at 12:55 AM
News Article Fresenius Medical Care Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Allocation Framework to further enhance Value Creation https://marketwirenews.com/news-releases/fresenius-medical-care-launches-its-strategy-fme-rei-5173163048165934.html $FMS
0 · Reply
wolverine
wolverine Jun. 17 at 9:11 AM
$CRMD $FMS capital markets day presentation: https://freseniusmedicalcare.com/content/dam/fresenius-medical-care/global/en/03_investors/pdf/events/cmd/2025/FME_CMD_2025_Main_Presentation.pdf
3 · Reply
GJ_Rockabilt
GJ_Rockabilt Jun. 11 at 2:25 PM
$FMS My son, in early twenties, needs a Kidney. He is "O Positive" Blood Type. Please, let me know if you are interested in donating one. Thanks.
0 · Reply
wolverine
wolverine Jun. 9 at 6:04 PM
$CRMD how do we think a $FMS & $CRMD initial order will be announced? Do they both announce? Does only Cormedix? Does $FMS announce at the capital markets day next Tuesday 6/17?
2 · Reply
ZacksResearch
ZacksResearch Jun. 4 at 5:18 PM
$FMS up 25.1% YTD — what’s fueling this growth? 🚀 This Zacks Rank #2 (Buy) stock is thriving with strategic acquisitions and partnerships, expecting a 9.6% bottom-line improvement in earnings over the next five years. The company has also beaten earnings estimates in the last four quarters with an average surprise of 6.6%. Discover the growth drivers for Fresenius Medical Care 👉"https://www.zacks.com/commentary/2484770/reasons-to-add-fresenius-medical-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2484770-body&ADID=SYND_STOCKTWITS_TWEET_2_2484770_BODY
0 · Reply
ZacksResearch
ZacksResearch Jun. 4 at 4:06 PM
$FMS gaining ground — but is it worth the risk? The stock’s momentum is being fueled by acquisitions and partnerships, but the regulatory backdrop isn’t exactly smooth sailing. Full bull/bear setup here 👉 https://www.zacks.com/stock/news/2484770/reasons-to-add-fresenius-medical-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2484770-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2484770_TEASER
0 · Reply
Quantumup
Quantumup Jun. 4 at 1:21 PM
Lucid Capital🏁 $UNCY Buy-$12 and said "We are initiating coverage of Unicycive with a Buy rating and a $12/share 12-month Price Target" - "We estimate that OLC could capture >$1.3B in peak sales in the US within two years after launch in 2025" $TAK $SNY $ARDX AKBA $FMS Lucid Capital additionally said in its initiation report:
1 · Reply
GJ_Rockabilt
GJ_Rockabilt Jun. 3 at 4:06 PM
$FMS Fresenius Partner Humacyte, gave tremendous News, today. https://www.globenewswire.com/news-release/2025/06/02/3091791/0/en/Humacyte-Clinical-Results-in-High-Risk-Dialysis-Patients-from-V007-Pivotal-Phase-3.html
0 · Reply
wolverine
wolverine May. 29 at 2:53 PM
$CRMD what are the next events? Jeffries 6/5? I don’t think much will be said here. $FMS capital markets day 6/15? Do we hope for a run up into the Fresinius event?
1 · Reply
tobyford84
tobyford84 May. 14 at 8:34 PM
$ICU it means we no longer need $FMS to make our stuff, nice move towards independence, shows confidence
2 · Reply
GJ_Rockabilt
GJ_Rockabilt May. 14 at 3:11 PM
$FMS Partner Humacyte's HUMA and HUMAW are Squeezin'. Dont miss jt..I Own HUMAW. Go, Fresenius!
0 · Reply
wolverine
wolverine May. 13 at 5:47 PM
$CRMD so now that the mm and big money are back in control with this low volume, what are the next big upcoming events? Still 7303 open options for 6/20 $20 call so we have $FMS capital markets day on 6/5? Early results from study with US Renal? What else am I missing?
3 · Reply
Stonehands
Stonehands May. 12 at 6:36 PM
$CRMD Lets effing go $DVA and $FMS! Lives depend on Defencath. https://www.woodtv.com/news/nexstar-media-wire/drug-resistant-fungus-candida-auris-reported-in-michigan/
1 · Reply
Noname2022
Noname2022 May. 10 at 10:32 PM
$CRMD $DVA $FMS This Mother’s Day, someone’s mom won’t make it — not because the infection was unstoppable, but because the solution wasn’t used. DefenCath is FDA-approved. Reduces deadly infections. Still waiting in too many places. When prevention is possible and you delay, that’s not caution — it’s a choice.
1 · Reply
Estimize
Estimize May. 7 at 10:00 AM
Wall St is expecting 0.50 EPS for $FMS Q2 [Reporting 08/05 BMO] http://www.estimize.com/intro/fms?chart=historical&metric_name=eps&utm_cont
0 · Reply
GJ_Rockabilt
GJ_Rockabilt May. 6 at 7:55 PM
$FMS Fresenius Strategic Ally Humacyte's HUMA, HUMAW Poised. Institutional Off Exchange Short Ratio (including Dark Pools Volume) fell over 20%, since yesterday, to ONLY 50.16%! Overall Short Interest percentsge of Float is, currently 21.13%. Thank you, Fintel, FINRA. Reversal possible. There us Risk. Do your Due Diligence. I Own HUMAW, and have Owned HUMA in the past. Go, Fresenius! Two CKD Patients here on Hemo.
0 · Reply